Search for: "johnson" Results 4481 - 4500 of 32,312
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2016, 7:24 am by Jim Higgins
The award is 28 times greater than the highest jury verdict previously decided against Janssen, a Johnson & Johnson subsidiary, in Philadelphia-based Risperdal litigation. [read post]
8 Dec 2017, 10:54 am by Dr. Shezad Malik
On the heels of the latest plaintiff multi-million dollar DePuy hip trial verdict, Johnson & Johnson (J&J), the world’s largest pharmaceutical company and medical device maker, and its DePuy subsidiary were back in federal court again. [read post]
4 May 2017, 3:08 pm by Angel Reyes III
It was recently announced a Pennsylvania state jury has awarded a New Jersey woman a $20 million verdict for injuries she suffered after receiving a pelvic mesh implant made by Ethicon, a subsidiary of Johnson & Johnson. [read post]
21 Jul 2011, 9:04 am by Mark Zamora
A South Carolina judge has rules that Johnson & Johnson must pay $327 million for deceptive marketing of its Risperdal antipsychotic medication.Judge Roger Couch chastised the company's management for allowing "the profit-at-all-costs mentality to cloud" their approach to marketing the drug. [read post]
13 Jul 2016, 6:05 am by Patrick A. Malone
That verdict, only for compensatory damages, was the latest rebuke to Johnson & Johnson over its drug Risperdal. [read post]
18 May 2018, 7:38 am by Clay Hodges
Recently, three cases in the Xarelto multi-district litigation (MDL) ended in defense verdicts in favor of Xarelto’s manufacturers, Bayer, Janssen, and Johnson & Johnson. [read post]
13 Jul 2016, 6:05 am by Patrick A. Malone
That verdict, only for compensatory damages, was the latest rebuke to Johnson & Johnson over its drug Risperdal. [read post]
13 Oct 2019, 8:33 am by Patrick A. Malone
That’s why Johnson & Johnson — and other drug makers — may want to heed the message in a just-announced $8-billion verdict in a Philadelphia courtroom in a case involving a young Baltimore patient and Risperdal, a prescription antipsychotic medication. [read post]
28 Mar 2011, 12:34 pm by Mark Zamora
., a Johnson & Johnson co., is voluntarily recalling hundreds of thousands of surgical drain products after customers complained that the packaging might not be sterile.The notice on Ethicon's Inc.'s says, "The company identified the potential for the sterile barrier of the product packaging to be compromised after receiving customer complaints. [read post]
7 Oct 2021, 9:55 am by Ronald V. Miller, Jr.
Earlier this year, Johnson & Johnson recalled several popular spray-on sunscreen products after testing found that the sunscreen contained benzene, a dangerous carcinogen. [read post]
24 Jun 2017, 11:26 am by Walter Olson
Johnson on Twitter] A fast-spreading fire at the North Kensington high-rise public housing tower resulted in more than 70 fatalities earlier this month. [read post]
30 Nov 2010, 2:03 pm
  Healthcare giant Johnson & Johnson announced yet another recall…this one involves four million cherry-and-grape flavored Children’s Benadryl allergy tablets and about 80,000 bottles of junior-strength Motrin caplets. [read post]
2 Jun 2010, 3:54 pm
Recently, Johnson & Johnson strengthened suicide warnings for two of its painkillers: Ultram and Ultracet. [read post]
17 Jul 2018, 6:47 am by Ezra Rosser
Abstract below: Panel moderated by Professor Olatunde Johnson, featuring Professors Monica Bell, Tanya K. [read post]
18 May 2018, 7:38 am by Clay Hodges
Recently, three cases in the Xarelto multi-district litigation (MDL) ended in defense verdicts in favor of Xarelto’s manufacturers, Bayer, Janssen, and Johnson & Johnson. [read post]
28 Oct 2019, 9:05 pm by Walter Olson
“A Philadelphia jury [October 8] ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. [read post]
16 Jan 2007, 10:36 am
Following its win over Genentech on Jan. 9, MedImmune prevailed over J&J's Centocor on Jan. 16 with the Supreme Court saying it can pursue a patent case against Johnson & Johnson subsidiary Centocor Inc. in a lower federal court, even though MedImmune is continuing to pay royalties on a patent held by Centocor.Both the Genentech and Centocor cases presented the issue of whether a company licensing a patent (a licensee) from another company (licensor) must take the risk… [read post]
9 Aug 2007, 5:09 am
Johnson & Johnson Sues Red Cross Over Symbol The dispute over rights to the symbol erupted to the surface yesterday in federal court in Manhattan, where J. [read post]